TestCloud
Prep • Practice • Perform
Log In

TPG Buys 35% Stake in SCHOTT Poonawalla from SII in Strategic Investment Deal.

Economy Business | Dated: 10 May 2025

In May 2025, Germany-based SCHOTT Pharma AG & Co. announced that United States (USA)-based global investment firm TPG Inc. has signed a binding agreement to acquire a 35% stake in its Indian joint venture (JV), SCHOTT Poonawalla Private Limited, from Pune (Maharashtra)-based Serum Institute of India Private Limited (SII), a key part of the Cyrus Poonawalla Group.

🎯 Key Highlights:

  • - This strategic acquisition aims to scale pharmaceutical packaging innovations and further strengthen the JV’s position in the global healthcare ecosystem.
  • - The transaction is routed through TPG Growth, TPG’s middle-market and growth equity platform. Novo Holdings A/S, based in Denmark, has joined as a co-investor, showcasing a strong global interest in India’s pharma packaging sector.

💡 Other Important Facts:

  • (i) After the deal, SCHOTT Pharma will retain its 50% stake in the joint venture, while SII will hold a minority stake, ensuring continued collaboration across the entities.
  • (ii) The partnership is set to enhance SCHOTT Poonawalla’s capacity to deliver high-quality pharmaceutical packaging solutions that meet international standards, reinforcing its role in supporting the global healthcare value chain.
  • (iii) Serum Institute of India (SII), part of the Cyrus Poonawalla Group, is the world’s largest vaccine manufacturer by volume. It was founded in 1966 by Dr. Cyrus Poonawalla.

📚 Test Your Knowledge:

Which global investment firm recently signed a binding agreement to acquire a 35% stake in SCHOTT Poonawalla Private Limited?

Correct Answer: TPG

🚀 Quick Recap: